INTERACTION OF EUROPIUM CHELATES WITH LIPID MONOLAYERS
Abstract
The ability of novel anticancer drug candidates, europium coordination complexes (EC), to penetrate the phospholipid monolayer composed of dimyristoylphosphatidylcholine (DMPC) was studied using Langmuir monolayer technique. EC were found to insert readily into the lipid monolayer with penetration extent being dependent on both drug structure and initial surface pressure of the lipid film. Evaluation of the limiting surface pressure revealed that all drugs are capable of inserting into the cellular membranes.
Downloads
References
Hill K., et al. Amphiphilic nature of new antitubercular drug candidates and their interaction with lipid monolayer // Progr. Colloid Polym. Sci. – 2008. – Vol. 135. – P. 87-92.
Peng J., Barnes G., Gentle I. The structure of LB films of fatty acids and salts // Adv. Colloid Interface Sci. – 2001. – Vol. 91. – P. 163-219.
Brockman H. Lipid monolayers: why use half of membrane to characterize protein-membrane interactions // Curr. Opin. Struct. Biol. – 1999. – Vol. 9. – P. 438-443.
Preetha A., Huilgol N., Banerjee R. Comparison of paclitaxel penetration in normal and cancerous cervical model monolayer membranes // Colloids Surfaces B: Biointerfaces. – 2006. – Vol. 53. – P. 179-186.
Seelig A. The use of monolayers for simple and quantitative analysis of lipid-drug interactions exemplified with dubicaine nd substance P // Cell Biol. Internat. Reports – 1990. – Vol.4. – P. 369-380.
Krill S., et al. Penetration of dimyrstoylphosphatidylcholine monolayers and bilayers by model beta-blocker agents of varying lipophilicity // J. Pharmaceut. Sci. – 1998. – Vol. 87. – P. 751-756.
Agasosler A., et al. Chlorpromazine-induced increase in dipalmitoylphosphatidylserine surface area in monolayers at room temperature // Biochem. Pharmacol. – 2001. – Vol. 61. – P. 817-825.
Yudintsev A., et al. Lipid bilayer interactions of Eu (III) tris - beta – diketonato coordination complex // Chem. Phys. Letters. – 2008. – Vol. 457. – P. 417-420.
Yudintsev A. Fluorescence study of interactions between europium coordination complex and model membranes / A. Yudintsev et al. // J. Biol. Phys. Chem. – 2010. – Vol. 10. – P. 55-62.
Momekov G., et al. Evaluation of the cytotoxic and pro-apoptotic activities of Eu(III) complexes with appended DNA intercalators in a panel of human malignant cell lines //Med. Chem. – 2006. – Vol. 2. – P. 439-445.
Bünzli J., Piguet C. Taking advantage of luminescent lanthanide ions // Chem. Soc. Rev. – 2005. – Vol. 34. – P. 1048-1077.
Vogler A., Kunkely H. Excited state properties of lanthanide complexes: beyond ff states // Inorg. Chim. Acta. – 2006. – Vol. 359. – P. 4130-4138.
Maas H., Curao A., Calzaferri G. Encapsulated lanthanides as luminescent materials // Angew. Chem. Int. Ed. – 2002. – Vol. 41. – P. 2495-2497.
Orcutt K., et al. A lanthanide-based chemosensor for bioavailable Fe3+ using a fluorescent siderophore: an assay displacementapproach // Sensors. – 2010. – Vol. 10. – P. 1326-1337.
Yuan J., Wang G. Lanthanide complex-based fluorescence label for time-resolved fluorescence bioassay // J. Fluoresc. – 2005. – Vol. 15. – P. 559-568.
Bakker B., et al. Luminescent materials and devices: lanthanide azatriphenylene complexes and electroluminescent charge transfer systems // Coord. Chem. Rev. – 2000. – Vol. 208. – P. 3-16.
Dean Sherry A. Lanthanide chelates as magnetic resonance imaging contrast agents // J. Less. Common Met. – 1989. – Vol. 149. – P. 133-141.
Thompson K., Orvig C. Lanthanide compounds for therapeutic and diagnostic applications // Chem. Soc. Rev. – 2006. – Vol. 35. – P. 499-499.
Kostova I. Lanthanides as anticancer drugs // Curr. Med. Chem. Anticancer Agents. – 2005. – Vol. 5. – P. 591-602.
Evans C. Interesting and useful biochemical properties of lanthanides // Trends Biochem. Sci. – 1983. – Vol. 8. – P. 445-449.
Calvez P., Bussieres S., Demers E., Salesse C. // Biochimie. – 2009. – Vol.91. – P.718-733.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).